Skip to content

Clinical trials

Completed Carcinoma, Ovarian Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Status: Completed Clear all

427 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200021
200126
200217
200320
200435
200526
200625
200729
20087
200914
201014
201112
201214
201314
20149
20158
20169
20177
20182
20198
20205
20214
20224
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed427

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)56
Gynecologic Oncology Group22
Fred Hutchinson Cancer Center21
Memorial Sloan Kettering Cancer Center21
City of Hope Medical Center10
European Organisation for Research and Treatment of Cancer - EORTC9
NCIC Clinical Trials Group7
University of Washington7
AGO Study Group6
Case Comprehensive Cancer Center6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial427
Ovarian Neoplasms250
Fallopian Tube Neoplasms168
Breast Neoplasms92
Carcinoma, Non-Small-Cell Lung52
Neoplasms50
Precursor Cell Lymphoblastic Leukemia-Lymphoma45
Leukemia, Lymphocytic, Chronic, B-Cell44
Lymphoma, Follicular44
Lymphoma, Large B-Cell, Diffuse44

Trials

Showing 51 to 75 of 427. Each trial links to its page on Pharma Observatory.

327 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.